Skip to content

PHARMAPLUS ROCOURT

Active Private limited companyfounded 1979active for 47 yearsChaussée de Tongres 431, 4000 LiègeKBO/BCE: BE 0419.680.693 subsidiary of

Lifetime

20 annual accounts with figures on one time axis, 47 filings since 1979
peak of €367,602 in 2021
€290,836▲ 32.1%
lowest -€65,326 in 2011
€32,216▲ 833%
peak of €131,792 in 2009
-€28,859▲ €32,216
€428,896▼ 18.5%
peak of 3.3 FTE in 2024
3.3 FTEunchanged
Board3 names since 2008
1 director
Owners
98%
Documentsfilings and deeds
14-04-2026108 days before the deadline
2025financial year
Gross margin from €220,080 to €290,836Result from €3,454 to €32,216Equity from -€61,075 to -€28,859Debts from €526,367 to €428,896Cash from €44,772 to €24,128

Key points

from the 2025 annual accounts

Equity

-€28,859
202020212022202320242025

Debts exceed assets in financial year 2025.

Turnover

≈ €1.0m estimated

The accounts state no turnover.

Debts

€428,896 107% of the balance sheet
Financial debts 32%Suppliers 40%Taxes and wages 5%Other 23%

Of this, €293,181 falls due within a year.

Filings

47 annual accounts since 1979
AprilJune31 JulyOctober1980199520102025

Two of the last ten came late. The 2016 accounts came in latest, 21 days after the end of the period.

Board

2 joined

New directors. Latest change 02-09-2026 · 3 in office.

Position in the sector

-7.2%

Lower solvency than 90% of companies in retail trade. Sector median 33.4% · 2,455 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 3,795 companies had the same profile as PHARMAPLUS ROCOURT has now. Each dot stands for 10 companies, two years later.

91.4%
were still trading
5.4%
stopped another way
2.7%
went bankrupt
  • Micro
  • 20 years or older
  • negative equity
  • a profit of 5% of the balance sheet or more

Another 0.6% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 3,795 companies, not a prediction for PHARMAPLUS ROCOURT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director,
Director,
Director,
  • 98%score equity €821,234 (2025) · annual accounts 2025 of
Board & ownership

Recent changes

Company renamed from PHARMA-FORME to PHARMAPLUS ROCOURT Registered office moved from Liège to Rocourt · The registered office moved from Place Reine-Astrid 2-4, 4000 Liège to Chaussée de Tongres 431, 4000 Rocourt · resigns as director · Gazette deed
1 director appointed, 1 resignation resigns · and act as permanent representatives · appointed · General meeting of 01-04-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0419680693
1 manager resigning, 1 director reappointed resigns as manager · reappointed as director · acts as permanent representative · General meeting of 05-12-2023 · Gazette deed
All 58 events

Comparable companies

same main activity, similar in size and age
Company
PHARMAPLUS ROCOURT Liège €400,037 €290,836 -7.2% 3.3
Pharmacie DETRY-DUPONT Faimes €394,516 €297,327 57.4% 2.9
PHARMACIE DE LA GRAND'PLACE Hannut €423,259 €338,502 -50.8% 3
Pharmacie J.P. Detry - Discry Faimes €500,505 €255,389 73.8% 3.7
APOTHEEK MATTHYSSEN Brasschaat €466,800 €282,271 74.1% 3.1
PHARMACIE WILLIAME - POULAERT Braine-l'Alleud €388,988 €265,069 27.3% 3.1
APOTHEEK WARLOP Antwerp €455,699 €226,908 65.5% 3

These companies have the same main activity as PHARMAPLUS ROCOURT: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €389,000 and €501,000, founded between 1974 and 1989.

Official details

Source: KBO
Status
Active since 30-03-1979Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.016.541.4134000 Liège, since 01-04-1979
Financial year end
31 December
Peppol
Reachable since 04-05-2026
Company details

Annual accounts 2025

€400,037▼ 14.0%
Employeeson 31-12-2025
5=
Filing
Filed on 14-04-2026, 108 days before the end of the filing period
Financials

Insights on PHARMAPLUS ROCOURT

PHARMAPLUS ROCOURT has existed since 1979. In 2009 the gross margin rose from €30,764 to €148,493.

Solvency rose in 2025 from -13.1% to -7.2% because of the retained profit and lower debts.

holds 98% of the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARMAPLUS ROCOURT

What is the company number of PHARMAPLUS ROCOURT?
The company number of PHARMAPLUS ROCOURT is 0419.680.693. The VAT number is the same number with BE in front: BE 0419.680.693.
Where is PHARMAPLUS ROCOURT based?
The registered office is at Chaussée de Tongres 431, 4000 Liège.Company details
What does PHARMAPLUS ROCOURT do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMAPLUS ROCOURT?
PHARMAPLUS ROCOURT is a private limited company (BV).
When was PHARMAPLUS ROCOURT founded?
PHARMAPLUS ROCOURT was founded on 30-03-1979.
Is PHARMAPLUS ROCOURT still active?
Yes, PHARMAPLUS ROCOURT is an active enterprise in the KBO register.
How many employees does PHARMAPLUS ROCOURT have?
PHARMAPLUS ROCOURT had an average of 3.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does PHARMAPLUS ROCOURT fall under?
In its 2025 annual accounts, PHARMAPLUS ROCOURT states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of PHARMAPLUS ROCOURT?
The turnover in financial year 2025 is ≈ €1.0m. This figure is estimated from the gross margin of €290,836 and 42 comparable companies (NACE 477). It probably lies between €790,000 and €1.4m.
Is PHARMAPLUS ROCOURT profitable?
In financial year 2025, PHARMAPLUS ROCOURT made a profit of €32,216.
Where can I find the annual accounts of PHARMAPLUS ROCOURT?
PHARMAPLUS ROCOURT filed 47 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMAPLUS ROCOURT due?
PHARMAPLUS ROCOURT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.